Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Patients With vs Without HIV - Infectious Disease Advisor

Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.

Patients with HIV infection without prior COVID-19 exposure had attenuated humoral responses to COVID-19 vaccination with NVX-CoV2373. These findings, from randomized, observer-blinded, multicenter, … [+3359 chars]

full article...